Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT03530241
Other study ID # IFC4
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date March 25, 2019
Est. completion date August 1, 2023

Study information

Verified date February 2024
Source Hvidovre University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background. X-ray cholangiography has a high sensitivity and specificity of detecting bile duct stones and is the gold standard. There are no studies describing the sensitivity and specificity of IFC for bile duct stone detection. Research question. What is the sensitivity of IFC to visualize bile duct stones? Method. Prospective study with 40 patients undergoing planned laparoscopic cholecystectomy with preoperative magnetic resonance cholangiopancreatography (MRCP) (gold standard) and intraoperative IFC, X-ray cholangiography and choledochuscopy in that order. Primary outcome. Sensitivity of visualization of bile duct stone by fluorescent cholangiography and secondary outcome is visualization of anatomy.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date August 1, 2023
Est. primary completion date October 31, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria - Patients suspected of having bile duct stones by either blood samples, MRCP or medical history (see definitions) - Patient age = 18 years - Preoperative MRCP - Operation performed by a project surgeon Exclusion criteria - Open cholecystectomy (including conversion from laparoscopic to open) - Acute cholecytitis or cholangitis - Pancreatitis - Iodine or indocyanine green allergy - Liver or renal insufficiency - Thyrotoxicosis - Cholecystectomy not the primary surgical procedure - Pregnancy or lactation - Legally incompetent for any reason - Withdrawal of inclusion consent at any time

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Presence of bile duct stones
MRCP verified gall stones in the bile ducts
Non-presence of bile duct stones
MRCP without bile duct stones

Locations

Country Name City State
Denmark Hvidovre University Hospital Holte Danmark

Sponsors (1)

Lead Sponsor Collaborator
Hvidovre University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sensitivity and specificity Sensitivity and specificity of visualization of bile duct stones by intraoperative fluorescent cholangiography 120mins
Secondary Visualization Visualization of the extrahepatic bile ducts 120mins
See also
  Status Clinical Trial Phase
Recruiting NCT05732480 - Influence of Gut Microbiome in Gallstone Disease